Journals / Infectious diseases and clinical microbiology (Online) / 2021 / Cilt: 3 - Sayı: 2

The Effects of Polypharmacy, Nutritional,Functional Status on the Progression ofCOVID-19 in Older Adults

Pages
70–77
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Functional dependence was associated with the need for intensive care and mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to evaluate the effects of nutritional factors, dependence in daily life activities, and polypharmacy on the length of hospitalization, clinical prognosis and mortality among hospitalized older COVID-19 patients.Materials and Methods: The charts of hospitalized COVID-19 patients older than 60 years old were reviewed retrospectively.
📊
Key Findings & Data:The Mini Nutritional Assessment (MNA), the Barthel Index for Activities of Daily Living (BADL) and the Lawton Instrumental Activities of Daily Living (IADL) Scale were used to analyze the findings.Results: Out of the 73 patients, 39 were female and the mean age was 69.65 ± 7.39 years.
💡
Conclusion & Impact:Functional dependence was associated with the need for intensive care and mortality.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to evaluate the effects of nutritional factors, dependence in daily life activities, and polypharmacy on the length of hospitalization, clinical prognosis and mortality among hospitalized older COVID-19 patients.Materials and Methods: The charts of hospitalized COVID-19 patients older than 60 years old were reviewed retrospectively. We obtained findings on admission, comorbidities and the number of drugs used. The Mini Nutritional Assessment (MNA), the Barthel Index for Activities of Daily Living (BADL) and the Lawton Instrumental Activities of Daily Living (IADL) Scale were used to analyze the findings.Results: Out of the 73 patients, 39 were female and the mean age was 69.65 ± 7.39 years. Fourteen (19.2%) patients were transferred to the intensive care unit, and nine (12.3%) of them died. After adjustment for age, the number of respiration at the first admission was significantly higher (p=0.001), and BADL, IADL scores and oxygen saturations were significantly lower (p=0.00, p=0.001) in the patients transferred to the intensive care unit compared to the patients discharged. There was no association between the length of hospitalization and age, the number of drugs, BADL and IADL scores, but there was a significant negative correlation between the length of hospitalization (r: -0.310), MNA score (r: -0.275) and daily protein intake (p=0.008). No association between polypharmacy and clinical progression of COVID-19 was detected (p=0.109).Conclusion: Decrease in MNA scores and daily protein intake in older COVID-19 patients were associated with prolonged hospitalization. Functional dependence was associated with the need for intensive care and mortality.

🔖

Cite This Article

SOYSAL, P., TAN, S. G., KAÇMAZ, A. B., GÜLEN, B., KOÇ, M. M., SÜMBÜL, B., OKAY, G., DURDU, B., AKKOYUNLU, Y., BÖLÜKCÜ, S., OGÜN, H., OKYALTIRIK, F. K., SÖNMEZ, E., KAZANCIOĞLU, R. (2022). The Effects of Polypharmacy, Nutritional,Functional Status on the Progression ofCOVID-19 in Older Adults. Infectious diseases and clinical microbiology (Online), Cilt: 3 - Sayı: 2, 70–77. https://ajindex.com/articles/539086

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020
  2. 55(6):105948. [CrossRef] 2 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020
  3. 323(13):1239-42. [CrossRef] 3 Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, Felix SEB, et al. Coronavirus disease 2019 case surveillance – United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020
  4. 69(24):759–65. [CrossRef] 4 Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. Jun, 2020
  5. 80(6):e14–e18. [CrossRef] 5 Miller EJ, Linge HM. Age-related changes in immunological and physiological responses following pulmonary challenge. Int J Mol Sci. 2017
  6. 18(6):1294. [CrossRef] 6 Boe DM, Boule LA, Kovacs EJ. Innate immune responses in the ageing lung. Clin Exp Immunol. 2017
  7. 187(1):16-25. [CrossRef] 7 Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. Apr, 2020
  8. 42(2):505-514. [CrossRef] 8 Hofman MR, van den Hanenberg F, Sierevelt IN, Tulner CR. Elderly patients with an atypical presentation of illness in the emergency department. The Neth J Med. 2017
  9. 75(6):241–6. 9 Iaccarino G, Grassi G, Borghi C, Ferii C, Salvetti M, Volpe M, et al. Age and multimorbidity predict death among COVID-19 patients: Results of the SARS-RAS study of the Italian Society of Hypertension. Hypertension. 2020
  10. 76(2):366-72. [CrossRef] 10 Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005
  11. 31(9):4-11. [CrossRef] 11 Byun S-E, Shon H-C, Kim JW, Kim HY, Sim Y. Risk factors and prognostic implications of aspiration pneumonia in older hip fracture patients: A multicenter retrospective analysis. Geriatr Gerontol Int. 2019
  12. 19(2):119–23. [CrossRef] 12 Bousquet G, Falgarone G, Deutsch D, Derolez S, Lopez-Sublet M, Goudot FX, et al. ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19. Aging (Albany NY). Jun 23, 2020
  13. 12(12):11306-13. [CrossRef] 13 T.C. Sağlık Bakanlığı COVID-19 Bilgilendirme